Acoustic evaluation of Isshiki type III thyroplasty for treatment of mutational voice disorders

被引:11
|
作者
Li, GD
Mu, LC
Yang, SL
机构
[1] CUNY, Mt Sinai Med Ctr, Dept Otolaryngol, Grabscheid Voice Ctr, New York, NY 10029 USA
[2] China Med Univ, 2nd Affiliated Hosp, Liaoning Voice Ctr, Dept Otolaryngol, Shenyang, Peoples R China
来源
JOURNAL OF LARYNGOLOGY AND OTOLOGY | 1999年 / 113卷 / 01期
关键词
voice disorders; voice quality; voice; surgery;
D O I
10.1017/S0022215100143099
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The goal of this study was to determine if there are acoustical differences between pre- and post-surgical voices and to evaluate the effectiveness of Isshiki type III thyroplasty in 11 male patients with mutational voice disorders. Acoustic measures were obtained both pre- and post-operatively. A comparison of pre- and post-operative fundamental frequency (Fo), voice frequencies, and vocal intensity obtained from a sustained vowel /i/ during different phonatory tasks was made. The results from the present study demonstrated that after operation the voice frequencies were significantly decreased (p<0.05). The vocal intensity tended to reduce slightly as the voice frequency lowered. However, there were no statistically significant differences in the pre- and post-operative measures of vocal intensity (p>0.5). The preoperative high pitched voices of all the male patients were lowered up to the normal value by the type III thyroplasty.
引用
收藏
页码:31 / 34
页数:4
相关论文
共 43 条
  • [41] Prospective Evaluation of ABL Kinase Domain Mutational Analysis By Next-Generation-Sequencing in Newly Diagnosed CP CML Patients Undergoing First-Line Treatment with Nilotinib Alone or Nilotinib plus Pegylated Interferon-α2a in a Prospective Phase III Trial
    de lavallade, Hugues
    Jackson, Sophie
    Kizilors, Aytug
    Etienne, Gabriel
    Huguet, Francoise
    Guerci-Bresler, Agnes
    Rea, Delphine
    Chollet, Claudine
    Morisset, Stephane
    Robbesyn, Fanny
    Mahon, Francois-Xavier
    Dulucq, Stephanie
    Nicolini, Franck E.
    BLOOD, 2019, 134
  • [42] Phase III, Randomized, Placebo-controlled Evaluation of Ferumoxytol Treatment for Iron Deficiency Anemia in Patients Who Have a History of Unsatisfactory Oral Iron Therapy: Fatigue and Health-related Quality of Life in Patients with Gastrointestinal Disorders
    Dahl, Naomi
    Ford, David
    Barish, Charles
    Bernard, Kristine
    DeBusk, Kendra
    Strauss, William
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S469 - S469
  • [43] Evaluation of Variable-Dose Treatment with a New US Botulinum Toxin Type A (Dysport) for Correction of Moderate to Severe Glabellar Lines: Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
    Kane, Michael A. C.
    Brandt, Fredric
    Rohrich, Rod J.
    Narins, Rhoda S.
    Monheit, Gary D.
    Huber, M. Barbara
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2009, 124 (05) : 1619 - 1629